These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1403764)

  • 21. Bleeding complications in both anticoagulated and nonanticoagulated surgical patients.
    Kent TL; Custer PL
    Ophthalmic Plast Reconstr Surg; 2013; 29(2):113-7. PubMed ID: 23328783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet inhibitor therapy. Agents and clinical implications.
    Webster MW; Chesebro JH; Fuster V
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):265-89. PubMed ID: 2179212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycythemia vera and mesenteric arterial thrombosis. A disease association resulting from decreased platelet sensitivity to aspirin.
    Myers TJ; Steinberg WM; Rickles FR
    Arch Intern Med; 1979 Jun; 139(6):695-8. PubMed ID: 443976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A warfarin-induced subconjunctival hemorrhage.
    Bodack MI
    Optometry; 2007 Mar; 78(3):113-8. PubMed ID: 17321459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation.
    Liu L; Duan JA; Tang Y; Guo J; Yang N; Ma H; Shi X
    J Ethnopharmacol; 2012 Jan; 139(2):381-7. PubMed ID: 22123200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antithrombogenic therapy based on the study of the changes in platelet aggregability and blood coagulability in the early period after prosthetic valve replacement].
    Takayama T
    Nihon Kyobu Geka Gakkai Zasshi; 1985 Jan; 33(1):14-24. PubMed ID: 3998524
    [No Abstract]   [Full Text] [Related]  

  • 28. Synergistic effect of a factor Xa inhibitor, TAK-442, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats.
    Konishi N; Hiroe K; Kawamura M
    Thromb Res; 2010 Aug; 126(2):124-9. PubMed ID: 20452654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of Cataract and Refractive Surgery members: survey.
    Ong-Tone L; Paluck EC; Hart-Mitchell RD
    J Cataract Refract Surg; 2005 May; 31(5):991-6. PubMed ID: 15975467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin.
    Chen G; Zhang W; Serenko M
    J Clin Pharmacol; 2015 Jun; 55(6):671-9. PubMed ID: 25641606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of subcutaneous administration of lactobionic acid on coagulation and platelet function].
    Kirchmaier CM; Lindhoff E; Basic-Micic M; Breddin HK
    Vasa Suppl; 1991; 33():168. PubMed ID: 1788660
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cataract operation during therapy with anticoagulants. Principles, perioperative procedure, complications and recommendations].
    Dick B; Stoffelns B; Pfeiffer N
    Ophthalmologe; 1997 May; 94(5):372-84. PubMed ID: 9273040
    [No Abstract]   [Full Text] [Related]  

  • 33. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antiplatelet agents and their therapeutic use].
    Lecompte T
    Rev Prat; 1999 Oct; 49(15):1627-33. PubMed ID: 10581992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
    Sudo T; Ito H; Ozeki Y; Kimura Y
    Br J Pharmacol; 2001 Aug; 133(8):1396-404. PubMed ID: 11498527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulants.
    Forbes CD; Prentice CR
    Practitioner; 1974 Oct; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of dipyridamole on coagulation status in stenocardia].
    Ficović P; Gjurić Z; Grgić Z
    Bilt Hematol Transfuz; 1978; 6(2):49-55. PubMed ID: 754694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
    Ben Ismail M; Ghariani M; Jais JM
    Nouv Presse Med; 1975 Mar; 4(10):746 (2). PubMed ID: 1129046
    [No Abstract]   [Full Text] [Related]  

  • 40. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.